Efficacy of [ 177 Lu]Lu-PSMA-617 With and Without Androgen Receptor Pathway Inhibitors for mAPM-R Prostate Cancer: Secondary Analysis of VISION
Journal of Nuclear Medicine · 19.11.2026 · jnumed.126.272954
DOI: 10.2967/jnumed.126.272954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 19.11.2026. Verfasst von Omid Yazdanpanah und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, University of California, Irvine, California; oyazdanp@hs.uci.edu. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, University of California, Irvine, California; oyazdanp@hs.uci.edu.
- Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
- Division of Medical Oncology, Department of Medicine, University of British Columbia, BC Cancer-Vancouver Center, Vancouver, British Columbia, Canada.
- Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom.
- Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida.
- Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Zitieren
APA
Yazdanpanah, O., Calais, J., Chi, K. N., de Bono, J., El-Haddad, G., Herrmann, K., Fizazi, K., Kendi, A. T., Krause, B., Morris, M. J., Nagarajah, J., Nordquist, L., Sartor, O., Rahbar, K., Tagawa, S. T., Vaishampayan, N., Ospina Gonzalez, D., Yue, Y., Carnahan, N., & Rezazadeh Kalebasty, A. (2026). Efficacy of [ 177 Lu]Lu-PSMA-617 With and Without Androgen Receptor Pathway Inhibitors for mAPM-R Prostate Cancer: Secondary Analysis of VISION. Journal of Nuclear Medicine, jnumed.126.272954. https://doi.org/10.2967/jnumed.126.272954
Vancouver
Yazdanpanah O, Calais J, Chi KN, de Bono J, El-Haddad G, Herrmann K, et al. Efficacy of [ 177 Lu]Lu-PSMA-617 With and Without Androgen Receptor Pathway Inhibitors for mAPM-R Prostate Cancer: Secondary Analysis of VISION. Journal of Nuclear Medicine. 2026:jnumed.126.272954. doi:10.2967/jnumed.126.272954
BibTeX
@article{Yazdanpanah2026,
author = {Yazdanpanah, Omid and Calais, Jeremie and Chi, Kim N and de Bono, Johann and El-Haddad, Ghassan and Herrmann, Ken and Fizazi, Karim and Kendi, Ayse Tuba and Krause, Bernd and Morris, Michael J and Nagarajah, James and Nordquist, Luke and Sartor, Oliver and Rahbar, Kambiz and Tagawa, Scott T and Vaishampayan, Nitin and Ospina Gonzalez, Diego and Yue, Ye and Carnahan, Natalie and Rezazadeh Kalebasty, Arash},
title = {Efficacy of [ 177 Lu]Lu-PSMA-617 With and Without Androgen Receptor Pathway Inhibitors for mAPM-R Prostate Cancer: Secondary Analysis of VISION},
journal = {Journal of Nuclear Medicine},
year = {2026},
pages = {jnumed.126.272954},
doi = {10.2967/jnumed.126.272954}
}
EUVIMED